SREBF2 and ovarian carcinoma: Similarly, CDDP-resistant ovarian cancer cells exhibit increased expression of key cholesterol metabolism genes, compared to treatment sensitive cells, including sterol regulatory-element binding protein 2, LDLR, and HMGCR, thereby suggesting that upregulated cholesterol metabolism might contribute to CDDP resistance in ovarian cancer [40].